Based on the property of proteopathic protein templated aggregation, we designed a tau capture assay to assess the recruitment ability of proteopathic tau by using AD O-tau as the proteopathic seeds, which we previously charactered as the most potent seeds in seeding tau aggregation in AD brain (Li et al., 2021). The gene discussed is MAPT; the disease is Alzheimer disease.